Ledger. Australian venture funding, tracked

Company

Sadleir Laboratories

IRIS, a precision drug-mixing syringe for delivering IV antibiotics to surgical patients with an antibiotic allergy label

Investors

Every investor coverage indicates participated in a round Sadleir Laboratories raised.

Investor Rounds Invested
No investors recorded yet. Know one?

Something wrong? Tell us